| Recruiting | An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Sympt NCT07078682 | Zenchi, Inc. | N/A |
| Not Yet Recruiting | CEH-EUS for Differentiating GISTs and Leiomyomas: A Multicenter Prospective Self-Controlled Study NCT07106411 | Huazhong University of Science and Technology | — |
| Recruiting | Multicenter Observational Study of Multimodal AI for Upper GI Mesenchymal Tumor Diagnosis NCT07078136 | Huazhong University of Science and Technology | — |
| Recruiting | Prescription of Letrozole for Uterine Myoma NCT06143631 | University of California, San Francisco | Phase 4 |
| Recruiting | Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study) NCT06135870 | Johns Hopkins University | — |
| Withdrawn | Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL) NCT05538689 | University of Chicago | Phase 4 |
| Unknown | Detective Flow Imaging Endoscopic Ultrasonography in Subepithelial Lesions NCT05474794 | Instituto Ecuatoriano de Enfermedades Digestivas | N/A |
| Unknown | Correlation Between Serum Vitamin D3 and Incidence of Uterine Leiomyoma NCT05151393 | Ain Shams University | — |
| Completed | Hemostatic Effect of Intrauterine Instillation of Oxytocin in Hysteroscopic Myomectomy NCT04996498 | Ain Shams Maternity Hospital | N/A |
| Completed | Dexamethasone for Post Uterine Artery Embolization Pain NCT04655144 | University of Miami | Phase 3 |
| Completed | Vitamin D Deficit in Women With Uterine Fibroids NCT04030182 | Instituto Mexicano del Seguro Social | — |
| Completed | Mechanistic Characterization of Uterine Pain NCT04145518 | Endeavor Health | Phase 4 |
| Unknown | The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures NCT04172272 | General Hospital Pula | N/A |
| Unknown | Development of a Predictive Model for Early Differential Diagnosis of Uterine Leiomyomas and Leiomyosarcomas NCT04214457 | Igenomix | — |
| Recruiting | Effects of Simvastatin on Uterine Leiomyoma Size NCT03400826 | Johns Hopkins University | Phase 2 |
| Unknown | Characterisation of Uterine Fibroid Tissue Stiffness NCT03369600 | Dr. Linda McLean | N/A |
| Unknown | Open Label Immunotherapy of Myoma NCT03550703 | Immunitor LLC | Phase 2 |
| Completed | Comparison of Pain of Two Different Methods in Uterine Artery Embolization NCT03420248 | Severance Hospital | N/A |
| Completed | OCL 500 Treatment of Women With Symptomatic Uterine Fibroids NCT03427671 | IMBiotechnologies Ltd. | N/A |
| Completed | Single Arm Study Using the Symphony -- MRI Guided Focused Ultrasound System for the Treatment of Leiomyomas NCT03323905 | Sunnybrook Health Sciences Centre | N/A |
| Terminated | Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery i NCT03342859 | Bayer | Phase 1 |
| Completed | Combined Vaginal Misoprostol and Perivascular Vasopressin NCT03815344 | Antonios Likourezos | Phase 4 |
| Completed | Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1002670 (Vilaprisan) NCT03092999 | Bayer | Phase 1 |
| Completed | Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids) NCT02889848 | Advance Biofactures Corporation | Phase 1 |
| Terminated | Concordance Between Sonography Amd MRI for Presurgical Diagnosis of Uterine Mesenchymal Malignant Tumors NCT02940041 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | — |
| Completed | Power Morcellation Systems for Laparoscopic Hysterectomy and Myomectomy NCT02777203 | Wake Forest University Health Sciences | N/A |
| Completed | Fertility After Myomectomy Versus Uterine Artery Embolization for Symptomatic Uterine Fibroids NCT02577055 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | New Inflammation Markers for Distinguishing Uterine Adenomyosis and Leiomyoma NCT02997787 | Kayseri Education and Research Hospital | — |
| Completed | A Multicenter Prospective Non-Interventional Study Assessing the Management of Canadian Women With Uterine Fib NCT02580578 | Allergan | — |
| Completed | Pilot of Letrozole for Uterine Myomas NCT02470741 | University of California, San Francisco | Phase 4 |
| Completed | Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids NCT02465814 | Bayer | Phase 2 |
| Completed | Superior Hypogastric Nerve Block for Pain Control Post-uterine Fibroid Embolization NCT02270255 | McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 2 |
| Completed | Bay1002670, Fibroids, Safety and Efficacy EU,US,Can, Jap NCT02131662 | Bayer | Phase 2 |
| Completed | Study of Tumor-shrinking Decoction (TSD) to Treat Symptomatic Uterine Fibroids NCT02189083 | The University of Hong Kong | Phase 3 |
| Completed | A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Ab NCT02147197 | Allergan | Phase 3 |
| Completed | A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding NCT02147158 | Allergan | Phase 3 |
| Completed | Impact of Misoprostol on Blood Loss In Myomectomy Operations NCT02061657 | Ain Shams University | Phase 3 |
| Completed | Vascular Function and Uterine Fibroids NCT02123069 | Mayo Clinic | — |
| Completed | Surgical Success After Laparoscopic vs Abdominal Hysterectomy NCT01793584 | University of Texas Southwestern Medical Center | N/A |
| Terminated | Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intraute NCT01998854 | Gynesonics | — |
| Terminated | Fibroid Ablation Study - Large Fibroids NCT01539187 | Gynesonics | N/A |
| Terminated | Study of Conventional Laparoscopic Hysterectomy Versus Robot-Assisted Laparoscopic Hysterectomy at a Teaching NCT01581905 | Milton S. Hershey Medical Center | N/A |
| Unknown | ESTD vs. VATS for Upper Gastrointestinal Submucosal Tumors NCT01768104 | Nanfang Hospital, Southern Medical University | N/A |
| Completed | Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670 NCT01816815 | Bayer | Phase 1 |
| Terminated | Fibroid Ablation Study NCT01226290 | Gynesonics | N/A |
| Terminated | Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine Fibroids NCT01311869 | Meharry Medical College | Phase 2 |
| Completed | Lower Urinary Tract Infection (UTI) Evaluation in Women With Uterine Leiomyomata NCT01123603 | The Cleveland Clinic | — |
| Withdrawn | Uterine Artery Embolization and Pelvic Floor Symptoms NCT00827645 | University of Texas Southwestern Medical Center | — |
| Completed | Novel MRI Strategies as a Non-invasive Biomarker in Women With Uterine Fibroids NCT00746031 | University of Edinburgh | Phase 4 |
| Completed | Post Market Study for an Adhesion Barrier Following Laparoscopic Myomectomy NCT00891657 | Integra LifeSciences Corporation | N/A |
| Withdrawn | Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ab NCT00768742 | Gynesonics | N/A |
| Completed | Hysteroscopic Cryomyolysis for the Treatment of Submucosal Leiomyomata NCT00731341 | Boston Scientific Corporation | N/A |
| Terminated | Establishment of Fibroid Tissue Bank NCT00710346 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | — |
| Unknown | Clinical Trial of Uterine Artery Embolization for Uterine Leiomyoma NCT00821275 | Sun Yat-sen University | Phase 2 / Phase 3 |
| Completed | Temporary Clipping of the Uterine Arteries During Laparoscopic Myomectomy NCT01530802 | Charite University, Berlin, Germany | N/A |
| Completed | Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlock™ Embolic Ag NCT00361036 | Worthington-Kirsch, Robert L., M.D. | Phase 1 |
| Unknown | Tissue Bank of Biological Specimens From Patients With Gynecologic Disease NCT00299481 | U.S. Army Medical Research and Development Command | — |
| Completed | Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914 NCT00290251 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Unknown | Far Infrared Radiation Treatment for Uterine Fibroids NCT00574418 | GAAD Medical Research Institute Inc. | Phase 1 |
| Completed | Magnetic Resonance (MR) Guided Focused Ultrasound Surgery of Uterine Fibroids NCT00131365 | InSightec | N/A |
| Completed | A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Ut NCT00628901 | Boston Scientific Corporation | Phase 4 |
| Unknown | Questionnaire Study to Assess Quality of Life After Treatment of Fibroids NCT00390494 | U.S. Army Medical Research and Development Command | — |
| Unknown | Health-Related QoL Among Women Receiving Hysterectomy in NTUH NCT00155870 | National Taiwan University Hospital | — |
| Terminated | A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas NCT00219778 | Poitiers University Hospital | Phase 2 |
| Completed | Study of Asoprisnil in the Treatment of Uterine Fibroids. NCT00156156 | Abbott | Phase 3 |
| Completed | Safety of Treatment of Uterine Fibroids With Asoprisnil NCT00156208 | Abbott | Phase 3 |
| Completed | Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids NCT00156195 | Abbott | Phase 3 |
| Completed | A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids NCT00152256 | Abbott | Phase 3 |
| Completed | Trial of Mifepristone for Fibroids NCT00133705 | University of Rochester | Phase 3 |
| Completed | A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hys NCT00150644 | Abbott | Phase 2 |
| Completed | Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist NCT00044876 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 2 |
| Completed | A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids NCT00160381 | Abbott | Phase 3 |
| Completed | Treatment of Uterine Fibroids With Asoprisnil(J867) NCT00152269 | Abbott | Phase 3 |
| Completed | Self-Hypnotic Relaxation Therapy During Invasive Procedures NCT00087841 | National Center for Complementary and Integrative Health (NCCIH) | Phase 2 |
| Completed | Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids NCT00100191 | ZonMw: The Netherlands Organisation for Health Research and Development | Phase 3 |
| Completed | A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids. NCT00156182 | Abbott | Phase 2 |
| Completed | A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids NCT00160459 | Abbott | Phase 2 |
| Terminated | Evaluation of Women With Endocrine and Reproductive-Related Conditions NCT00001850 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | — |